Literature DB >> 34143784

The role of the Basic Public Health Service program in the control of hypertension in China: Results from a cross-sectional health service interview survey.

Jiangmei Qin1, Yanchun Zhang1, Masha Fridman2, Kim Sweeny2, Lifang Zhang1, Chunmei Lin1, Lu Mao3.   

Abstract

OBJECTIVES: Non-communicable diseases (NCDs) have become the main cause of mortality in China. In 2009, the Chinese government introduced the Basic Public Health Service (BPHS) program to relieve the rising burden of NCDs through public health measures and delivery of essential medical care. The primary aim of this study was to evaluate the impact of the BPHS program on hypertension control.
METHODS: The China National Health Development Research Center (CNHDRC) undertook a Cross-sectional Health Service Interview Survey (CHSIS) of 62,097 people from primary healthcare reform pilot areas across 17 provinces from eastern, central, and western parts of China in 2014. The current study is based on responses to the CHSIS survey from 7,867 participants, who had been diagnosed with hypertension. Multi-variable mixed logit regression analysis was used to estimate the association between BPHS management and uncontrolled hypertension. In a follow-up analysis, generalized structural equation modelling (GSEM) was used to test for mediation of the BPHS program effect through patient compliance with medication.
FINDINGS: The estimated proportion of patients with uncontrolled hypertension was 30% lower (23.2% vs 31.5%) in those participants who were adequately managed under the BPHS program. Other predictors of hypertension control included compliance with medication, self-reported wellbeing, income, educational attainment and exercise; smoking was associated with reduced hypertension control. The significant inverse association between uncontrolled hypertension and age indicates poor outcomes for younger patients. Additional testing suggested that nearly 40% of the effect of BPHS management (95% CI: 28.2 to 51.7) could be mediated by improved compliance with medication; there was also an indication that the effect of management was 30% stronger in districts/counties with established digital information management systems (IMS).
CONCLUSION: Hypertension control improved markedly following active management through the BPHS program. Some of that improvement could be explained by greater compliance with medication among program participants. This study also identified the need to tailor the BPHS program to the needs of younger patients to achieve higher levels of control in this population. Future investigations should explore ways in which existing healthcare management influences the success of the BPHS program.

Entities:  

Year:  2021        PMID: 34143784     DOI: 10.1371/journal.pone.0217185

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  4 in total

1.  Urban-rural disparities in hypertension prevalence, awareness, treatment, and control among Chinese middle-aged and older adults from 2011 to 2015: a repeated cross-sectional study.

Authors:  Haozhe Cheng; Yiran Gu; Xiaochen Ma; Haoqing Tang; Xiaoyun Liu
Journal:  BMC Cardiovasc Disord       Date:  2022-07-17       Impact factor: 2.174

2.  Evaluating Behavioral Risk Factor Interventions for Hypertensive and Diabetic Patient Management in the National Basic Public Health Service Programs from 2009.

Authors:  Liuxia Yan; Ning Ji; Jian Xu; Min Liu; Lizheng Guan; Kejun Liu; Ainan Jia; Xianbin Ding; Dan Liu; Man Li; Yanfang Zhao; Shengquan Mi; Wenhua Zhao; Zhuoqun Wang; Yamin Bai
Journal:  China CDC Wkly       Date:  2022-05-13

3.  Medication Adherence and Perceived Social Support of Hypertensive Patients in China: A Community-Based Survey Study.

Authors:  Bingjie Shen; Tianjia Guan; Xinyu Du; Chenyang Pei; Jinhong Zhao; Yuanli Liu
Journal:  Patient Prefer Adherence       Date:  2022-05-18       Impact factor: 2.314

4.  Effectiveness of a Transtheoretical Model-Based Intervention to Improve Blood Pressure Control of Hypertensive Patients in China: A Clustered Randomized Controlled Trial.

Authors:  Ping Chen; Ying Shen; Chao He; Xinying Sun
Journal:  Front Public Health       Date:  2022-01-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.